A collage photo of David Gandara and Joel W. Neal
Oct 7, 2024, 16:03
David Gandara: Joel W. Neal on targeted therapies at WCLC24
David Gandara shared a post on X:
“Best of WCLC24 in San Francisco.
Joel W. Neal, ‘Sets the Stage’ for the session on targeted therapies.
Fabulous conference highlighting important abstracts from our recent IASLC WCLC.”
Source: David Gandara/X
David Gandara is the Co-Director-Center for Experimental Therapeutics and a professor at UC Davis Comprehensive Cancer Center. His research interests focus on developmental therapeutics of new anti-cancer agents as well as preclinical modeling and clinical research in lung cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 9, 2025, 17:52
Aug 9, 2025, 17:47
Aug 9, 2025, 17:12
Aug 9, 2025, 17:05